Dewdrop Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.60 M
- Paid Up Capital ₹ 0.56 M
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
About Dewdrop Lifesciences
Dewdrop Lifesciences Private Limited (DLPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 August 2014 and has a history of Ten years and five months. Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.60 M and a paid-up capital of Rs 0.56 M, as per Ministry of Corporate Affairs (MCA) records.
Tushar Shah, Gunjan Arvindbhai, Geetaben Patel, and Three other members serve as directors at the Company.
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U51101GJ2014PTC080428
- Company No.
080428
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Aug 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Dewdrop Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tushar Shah  | Managing Director | 11-Aug-2014 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gunjan Arvindbhai | Director | 25-Mar-2015 | Current |
| Geetaben Patel | Director | 25-Mar-2015 | Current |
| Madhusudan Mahasukhlal | Director | 25-Mar-2015 | Current |
| Vijay Chandulal | Director | 25-Mar-2015 | Current |
| Girish Mahijibhai | Additional Director | 25-Mar-2015 | Current |
Financial Performance of Dewdrop Lifesciences.
Dewdrop Lifesciences Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dewdrop Lifesciences?
In 2017, Dewdrop Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Quali - Health Care Private LimitedTushar Shah is a mutual person
- Apex Plastic Surgery Llp
Gunjan Arvindbhai is a mutual person
- Adstrum Laboratories Private Limited
Geetaben Patel is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dewdrop Lifesciences?
Unlock and access historical data on people associated with Dewdrop Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dewdrop Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dewdrop Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
